Oncology Corporate Profile
TetraLogic Pharmaceuticals is a leader in the discovery and development of small molecule drugs called Smac mimetics for the treatment of cancers. Smac mimetics are an entirely new class of targeted drugs that specifically induce cancer cell death and inhibit fundamental mechanisms of cancer cell survival and resistance, enabling tumors to die. TetraLogic's lead Smac mimetic drug, birinapant, is in Phase 2 clinical trials and is being developed for both solid tumors and hematological malignancies as a single agent and in combination with several standard-of-care cancer therapies.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|birinapant||peptidomimetic of Smac||Myelodysplastic Syndrome (MDS)||II|
|birinapant||peptidomimetic of Smac||Ovarian cancer||II|
|birinapant||peptidomimetic of Smac||Colorectal cancer||I|
|birinapant||peptidomimetic of Smac||Cutaneous T-cell Lymphoma (CTCL)||I|
|TL32711||peptidomimetic of Smac||Elderly patients with Acute Myelogenous Leukemia (AML)||I|
|TL32711||peptidomimetic of Smac||Various cancer types||I|
|TL32711 (+ chemotherapy)||peptidomimetic of Smac||Various cancer types||I|
View additional information on product candidates here »
12/30/2016 01:02 pm
12/29/2016 03:03 pm
[GlobeNewswire] - PAOLI, Pa., Dec. 29, 2016-- TetraLogic Pharmaceuticals Corporation and its wholly-owned subsidiary TetraLogic Research and Development Corporation today announced that they have completed the sale to Medivir ...
11/22/2016 01:02 pm
11/15/2016 06:00 pm
11/14/2016 10:00 pm
11/4/2016 04:02 pm
11/3/2016 09:02 pm
11/2/2016 10:00 pm
[at noodls] - TetraLogic Pharmaceuticals Corporation (NASDAQ: TLOG) ('TetraLogic' or 'Company'), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in ...
11/2/2016 08:05 pm
11/2/2016 08:04 pm
[at noodls] - Press release as PDF Stockholm, Sweden - Medivir AB (Nasdaq Stockholm: MVIR)today announces that it has entered into an agreement to acquire two clinical stage oncology programs from Tetralogic Pharmaceuticals ...
11/2/2016 08:03 pm
[GlobeNewswire] - PAOLI, Pa., Nov. 02, 2016-- TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious ...
11/2/2016 08:03 pm
10/19/2016 08:00 pm
9/6/2016 08:00 pm
9/1/2016 08:00 pm
8/11/2016 05:02 pm
7/22/2016 08:01 pm
7/20/2016 08:02 pm
7/18/2016 01:04 pm
6/15/2016 08:00 pm
5/4/2016 05:03 pm
4/26/2016 12:02 pm
[Accesswire] - NEW YORK, NY / ACCESSWIRE / April 26, 2016 / The OTC Expert is issuing a report on four stocks that are trading with heavier than usual volume. LPTN , TLOG , HTM and VSTM are on high volume watch. Continue ...